Alcon

Yahoo Finance • yesterday

Earnings week ahead: WMT, HD, TGT, BIDU, ZM, MDT, ZIM, PANW, and more

[Concept shopping online. hand man shopper using a laptop computer touch add to cart icon. business, store,e-commerce technology internet, shopping service on the online web and offers home delivery.] Buntiam/iStock via Getty Images Next... Full story

Yahoo Finance • 9 days ago

Key deals this week: Walt Disney, Harrison Global, Alcon, Steelcase, Joby Aviation and more

Here's a list of key deals reported across sectors this week: * Walt Disney’s (DIS [https://seekingalpha.com/symbol/DIS]) ESPN has reached a non-binding deal [https://seekingalpha.com/news/4479427-disneys-espn-to-acquire-nfl-media-asset... Full story

Yahoo Finance • 11 days ago

Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition

Investing.com - Stifel downgraded STAAR Surgical (NASDAQ:STAA) from Buy to Hold while raising its price target to $28.00 from $20.00 following the proposed acquisition by Alcon (NYSE:ALC). The stock has surged over 50% in the past week,... Full story

Yahoo Finance • 13 days ago

Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in conne... Full story

Yahoo Finance • 13 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)

BALA CYNWYD, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 13 days ago

STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal

Investing.com - STAAR Surgical (NASDAQ:STAA) stock rating was downgraded from Buy to Neutral by Sidoti on Tuesday, following the announcement of a definitive acquisition agreement with Alcon Inc. (NYSE:ALC). According to InvestingPro dat... Full story

Yahoo Finance • 13 days ago

STAAR Surgical stock price target raised to $28 from $20 at Canaccord

Investing.com - Canaccord Genuity raised its price target on STAAR Surgical (NASDAQ:STAA) to $28.00 from $20.00 on Tuesday, while maintaining a Hold rating on the stock. According to InvestingPro data, STAAR maintains a strong balance sh... Full story

Yahoo Finance • 13 days ago

Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition

On Tuesday, the eye care company Alcon Plc (NYSE:ALC) agreed to acquire STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the implantable collamer lens (ICL). The acquisition includes the EVO family of lenses (EVO ICL) for vision... Full story

Yahoo Finance • 13 days ago

Alcon Strikes $1.5 Billion Deal to Acquire STAAR Surgical

Alcon (ALC) on Tuesday agreed to acquire eye lens manufacturer STAAR Surgical (STAA) in a deal worth PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 13 days ago

Alcon to buy eye health firm STAAR Surgical for $1.5 bln

Investing.com-- Eye care firm Alcon AG (NYSE:ALC) said on Tuesday it had entered a definitive agreement to buy U.S.-listed peer STAAR Surgical Company (NASDAQ:STAA) in an all cash deal for an equity value of $1.5 billion. Alcon will pay... Full story

Yahoo Finance • 26 days ago

Should You Continue to Hold Alcon (ALC)?

Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. Although the U.S. equity market started with volati... Full story

Yahoo Finance • 27 days ago

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

MarketNewsUpdatesNews Commentary NEW YORK, July 22, 2025 /CNW/ -- According to a report from Research And Markets, the AI in Ophthalmology Market was valued at USD 209.23 million in 2024, and is projected to reach USD 1.36 billion by 2030... Full story

Yahoo Finance • last month

Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more

[Top view of business office workstation with M&A letters or merger and acquisition] Atstock Productions Here's a list of key deals reported across sectors this week: Meta Platforms (NASDAQ:META [https://seekingalpha.com/symbol/META]) is... Full story

Yahoo Finance • last month

Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens

Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now.On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in Canada. PanOptix Pro uses proprietary EN... Full story

Yahoo Finance • 2 months ago

DP World subsidiary to acquire 51% stake in NovaAlgoma cement assets

LUGANO, Switzerland - NovaAlgoma Cement Carriers Limited announced Thursday it has entered a definitive agreement with P&O Maritime Logistics (POML), a DP World subsidiary, for POML to acquire a 51% controlling stake in NovaAlgoma’s wholly... Full story

Yahoo Finance • 2 months ago

Stifel reiterates Buy rating on Alcon stock amid IOL market dynamics

Investing.com - Stifel has reiterated its Buy rating on Alcon Inc. (NYSE:ALC), a $44.4 billion eye care company currently trading near its 52-week low. According to InvestingPro analysis, Alcon maintains a GREAT financial health score, wit... Full story

Yahoo Finance • 2 months ago

UBS downgrades Galderma to “neutral” on valuation concerns, softer aesthetics

Investing.com -- UBS has downgraded Galderma Group AG (SIX:GALD) to “neutral” from “buy,” citing limited upside following strong share price performance, in a note dated Monday. The decision reflects a more cautious stance on the inject... Full story

Yahoo Finance • 2 months ago

Alcon Canada Earns Global Recognition as a Top Employer

Certification as a Top Employer in Canada issued by the Top Employers InstitutePeople Strategy, Career Development, Rewards and Recognition, Purpose and Values, and Diversity & Inclusion noted as Alcon Canada’s top performance areas TORON... Full story

Yahoo Finance • 3 months ago

Alcon Inc. (ALC)’s TRYPTYR Wins FDA Nod for Dry Eye Disease

Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ophthalmic solution) 0.003% for the treatment of signs and symptoms of Dry Eye Disease (DED), marking a major milestone f... Full story

Yahoo Finance • 2 years ago

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Lifecore Biomedical, Inc. Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and BMO CHASKA, M... Full story